HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120

FEBS Letters

Volumn 587, Issue 7, 2013, Pages 860-866

  Hoorelbeke, Bart ^a   Van Montfort, Thijs ^b   Xue, Jie ^c   Liwang, Patricia J ^c   Tanaka, Haruo ^d   Igarashi, Yasuhiro ^e   Van Damme, Els J M ^f   Sanders, Rogier W ^b,g   Balzarini, Jan ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d IWAKI MEISEI UNIVERSITY   (Japan)

^e TOYAMA PREFECTURAL UNIVERSITY   (Japan)

^f GHENT UNIVERSITY   (Belgium)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Carbohydrate binding agent; High mannose N glycan; Monomeric gp120; Surface plasmon resonance; Trimeric gp140

Indexed keywords

GLYCAN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 140; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; MANNOSE OLIGOSACCHARIDE; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SURFACE PLASMON RESONANCE; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS PARTICLE;

ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; BINDING, COMPETITIVE; BLOTTING, WESTERN; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HEK293 CELLS; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; KINETICS; MANNOSE; PLANT LECTINS; POLYSACCHARIDES; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SURFACE PLASMON RESONANCE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84875233502     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.02.037     Document Type: Article

References (39)

1. E.P. Go, Q. Chang, H.X. Liao, L.L. Sutherland, S.M. Alam, B.F. Haynes, and H. Desaire Glycosylation site-specific analysis of clade C HIV-1 envelope proteins J. Proteome Res. 8 2009 4231 4242
2. M. Sagar, X. Wu, S. Lee, and J. Overbaugh Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity J. Virol. 80 2006 9586 9598
3. C. Bonomelli, K.J. Doores, D.C. Dunlop, V. Thaney, R.A. Dwek, D.R. Burton, M. Crispin, and C.N. Scanlan The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade PLoS One 6 2011 e23521
4. H. Tanaka, H. Chiba, J. Inokoshi, A. Kuno, T. Sugai, A. Takahashi, Y. Ito, M. Tsunoda, K. Suzuki, A. Takénaka, T. Sekiguchi, H. Umeyama, J. Hirabayashi, and S. Omura Mechanism by which the lectin actinohivin blocks HIV infection of target cells Proc. Natl. Acad. Sci. USA 106 2009 15633 15638
5. M.R. Boyd, K.R. Gustafson, J.B. McMahon, R.H. Shoemaker, B.R. O'Keefe, T. Mori, R.J. Gulakowski, L. Wu, M.I. Rivera, C.M. Laurencot, M.J. Currens, J.H. Cardellina 2nd, R.W. Buckheit Jr.; P.L. Nara, L.K. Pannell, R.C. Sowder 2nd, and L.E. Henderson Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development Antimicrob. Agents Chemother. 41 1997 1521 1530
6. J.C. Kehr, Y. Zilliges, A. Springer, M.D. Disney, D.D. Ratner, C. Bouchier, P.H. Seeberger, N.T. de Marsac, and E. Dittmann A mannan binding lectin is involved in cell-cell attachment in a toxic strain of Microcystis aeruginosa Mol. Microbiol. 59 2006 893 906
7. T. Mori, B.R. O'Keefe, R.C. Sowder 2nd, S. Bringans, R. Gardella, S. Berg, P. Cochran, J.A. Turpin, R.W. Buckheit Jr.; J.B. McMahon, and M.R. Boyd Isolation and characterization of griffithsin, a novel HIV-inactivating protein, from the red alga Griffithsia sp J. Biol. Chem. 280 2005 9345 9353
8. J. Balzarini, K. Van Laethem, S. Hatse, M. Froeyen, E. Van Damme, A. Bolmstedt, W. Peumans, E. De Clercq, and D. Schols Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis Mol. Pharmacol. 67 2005 1556 1565
9. J. Balzarini, J. Neyts, D. Schols, M. Hosoya, E. Van Damme, W. Peumans, and E. De Clercq The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro Antiviral Res. 18 1992 191 207
10. J. Balzarini, K. Van Laethem, D. Daelemans, S. Hatse, A. Bugatti, M. Rusnati, Y. Igarashi, T. Oki, and D. Schols Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus J. Virol. 81 2007 362 373
11. J. Balzarini, K.O. François, K. Van Laethem, B. Hoorelbeke, M. Renders, J. Auwerx, S. Liekens, T. Oki, Y. Igarashi, and D. Schols Pradimicin S, a highly soluble nonpeptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use Antimicrob. Agents Chemother. 54 2010 1425 1435
12. J. Balzarini Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy Nat. Rev. Microbiol. 5 2007 583 597
13. J. Balzarini, Y. Van Herrewege, K. Vermeire, G. Vanham, and D. Schols Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes Mol. Pharmacol. 71 2007 3 11
14. C.C. Tsai, P. Emau, Y. Jiang, M.B. Agy, R.J. Shattock, A. Schmidt, W.R. Morton, K.R. Gustafson, and M.R. Boyd Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models AIDS Res. Hum. Retroviruses 20 2004 11 18
15. C.C. Tsai, P. Emau, Y. Jiang, B. Tian, W.R. Morton, K.R. Gustafson, and M.R. Boyd Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques AIDS Res. Hum. Retroviruses 19 2003 535 541
16. P. Zhu, J. Liu, J. Bess Jr.; E. Chertova, J.D. Lifson, H. Grisé, G.A. Ofek, K.A. Taylor, and K.H. Roux Distribution and three-dimensional structure of AIDS virus envelope spikes Nature 441 2006 847 852
17. P. Poignard, E.O. Saphire, P.W. Parren, and D.R. Burton Gp120: biologic aspects of structural features Annu. Rev. Immunol. 19 2001 253 274
18. J.M. Binley, R.W. Sanders, B. Clas, N. Schuelke, A. Master, Y. Guo, F. Kajumo, D.J. Anselma, P.J. Maddon, W.C. Olson, and J.P. Moore A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure J. Virol. 74 2000 627 643
19. A. Harris, M.J. Borgnia, D. Shi, A. Bartesaghi, H. He, R. Pejchal, Y.K. Kang, R. Depetris, A.J. Marozsan, R.W. Sanders, P.J. Klasse, J.L. Milne, I.A. Wilson, W.C. Olson, J.P. Moore, and S. Subramaniam Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures Proc. Natl. Acad. Sci. USA 108 2011 11440 11445
20. M. Melchers, I. Bontjer, T. Tong, N.P. Chung, P.J. Klasse, D. Eggink, D.C. Montefiori, M. Gentile, A. Cerutti, W.C. Olson, B. Berkhout, J.M. Binley, J.P. Moore, and R.W. Sanders Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses J. Virol. 86 2012 2488 2500
21. E.E. Tran, M.J. Borgnia, O. Kuybeda, D.M. Schauder, A. Bartesaghi, G.A. Frank, G. Sapiro, J.L. Milne, and S. Subramaniam Structural mechanism of trimeric HIV-1 envelope glycoprotein activation PLoS Pathog. 8 2012 e1002797
22. J. Celigoy, B. Ramirez, L. Tao, L. Rong, L. Yan, Y.R. Feng, G.V. Quinnan, C.C. Broder, and M. Caffrey Probing the HIV gp120 envelope glycoprotein conformation by NMR J. Biol. Chem. 286 2011 23975 23981
23. P. Di Gianvincenzo, F. Chiodo, M. Marradi, and S. Penadés Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes Methods Enzymol. 509 2012 21 40
24. M. Brigham-Burke, J.R. Edwards, and D.J. O'Shannessy Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction Anal. Biochem. 205 1992 125 131
25. H. Liu, M. Geng, X. Xin, F. Li, Z. Zhang, J. Li, and J. Ding Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities Glycobiology 15 2005 501 510
26. J.I. Jay, B.E. Lai, D.G. Myszka, A. Mahalingam, K. Langheinrich, D.F. Katz, and P.F. Kiser Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors Mol. Pharm. 7 2010 116 129
27. A.K. Dey, C. Griffiths, S.M. Lea, and W. James Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1 RNA 11 2005 873 884
28. S.K. Gift, I.J. Zentner, A. Schön, K. McFadden, M. Umashankara, S. Rajagopal, M. Contarino, C. Duffy, J.R. Courter, M.Y. Zhang, J.M. Gershoni, S. Cocklin, D.S. Dimitrov, A.B. Smith 3rd, E. Freire, and I.M. Chaiken Conformational and structural features of HIV-1 gp120 underlying the dual receptor antagonism by cross-reactive neutralizing antibody m18 Biochemistry 50 2011 2756 2768
29. D. Eggink, M. Melchers, M. Wuhrer, T. van Montfort, A.K. Dey, B.A. Naaijkens, K.B. David, V. Le Douce, A.M. Deelder, K. Kang, W.C. Olson, B. Berkhout, C.H. Hokke, J.P. Moore, and R.W. Sanders Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function Virology 401 2010 236 247
30. P.J. Reeves, N. Callewaert, R. Contreras, and H.G. Khorana Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N- acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line Proc. Natl. Acad. Sci. USA 99 2002 13419 13424
31. S. Zolla-Pazner Identifying epitopes of HIV-1 that induce protective antibodies Nat. Rev. Immunol. 4 2004 199 210
32. J.M. Binley, T. Wrin, B. Korber, M.B. Zwick, M. Wang, C. Chappey, G. Stiegler, R. Kunert, S. Zolla-Pazner, H. Katinger, C.J. Petropoulos, and D.R. Burton Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies J. Virol. 78 2004 13232 13252
33. E. van Liempt, C.M. Bank, P. Mehta, J.J. Garciá-Vallejo, Z.S. Kawar, R. Geyer, R.A. Alvarez, R.D. Cummings, Y. Kooyk, and I. van Die Specificity of DC-SIGN for mannose- and fucose-containing glycans FEBS Lett. 580 2006 6123 6131
34. E.A. Koppel, K.P. van Gisbergen, T.B. Geijtenbeek, and Y. van Kooyk Distinct functions of DC-SIGN and its homologues L-SIGN (DC-SIGNR) and mSIGNR1 in pathogen recognition and immune regulation Cell Microbiol. 7 2005 157 165
35. T.B. Geijtenbeek, and Y. van Kooyk Pathogens target DC-SIGN to influence their fate DC-SIGN functions as a pathogen receptor with broad specificity APMIS 111 2003 698 714
36. A.P. West Jr.; R.P. Galimidi, C.P. Foglesong, P.N. Gnanapragasam, K.E. Huey-Tubman, J.S. Klein, M.D. Suzuki, N.E. Tiangco, J. Vielmetter, and P.J. Bjorkman Design and expression of a dimeric form of human immunodeficiency virus type 1 antibody 2G12 with increased neutralization potency J. Virol. 83 2009 98 104
37. D.A. Calarese, C.N. Scanlan, M.B. Zwick, S. Deechongkit, Y. Mimura, R. Kunert, P. Zhu, M.R. Wormald, R.L. Stanfield, K.H. Roux, J.W. Kelly, P.M. Rudd, R.A. Dwek, H. Katinger, D.R. Burton, and I.A. Wilson Antibody domain exchange is an immunological solution to carbohydrate cluster recognition Science 300 2003 2065 2071
38. D.A. Calarese, H.K. Lee, C.Y. Huang, M.D. Best, R.D. Astronomo, R.L. Stanfield, H. Katinger, D.R. Burton, C.H. Wong, and I.A. Wilson Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12 Proc. Natl. Acad. Sci. USA 102 2005 13372 13377
39. E. Martines, I. García, M. Marradi, D. Padro, and S. Penadés Dissecting the carbohydrate specificity of the anti-HIV-1 2G12 antibody by single-molecule force spectroscopy Langmuir 28 2012 17726 17732